@ARTICLE{
author={Davies AJ,Merli Francesco,Mihaljevic Biljana S,Siritanaratkul Noppadol,Solal-Celigny Philippe,Boehnke Axel,Berge Claude,McIntyre Christine,Barrett M,MacDonald D},
year={2013},
title={Pharmacokinetics (PK), safety and overall response rate (ORR) achieved with subcutaneous (SC) administration of rituximab in combination with chemotherapy were comparable to those achieved with intravenous (IV) administration in patients (pts) with follicular lymphoma (FL) in the first-line setting: Stage 1 results of the phase III SABRINA study},
journal={BRITISH JOURNAL OF HAEMATOLOGY},
volume={161},
number={},
pages={7-8},
document_type={Meeting Abstract},
}